Skip to content

MAZE MAZE Operating Lease Liabilities

Operating Lease Liabilities at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.99B+29.2%
Septerna, Inc. logo
Septerna, Inc.SEPN
$20.78M-10.0%
Zymeworks logo
ZymeworksZYME
$13.76M-9.3%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$55.45M+177%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$4.67M
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$27.68M-32.9%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's operating lease liabilities?
MAZE (MAZE) reported operating lease liabilities of $17.55M in Q1 2026.
How has MAZE's operating lease liabilities changed year-over-year?
MAZE's operating lease liabilities decreased by 17.0% year-over-year, from $21.15M to $17.55M.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.